{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "23436141", "DateCompleted": {"Year": "2014", "Month": "02", "Day": "12"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s12035-013-8425-7"], "ArticleDate": [{"Year": "2013", "Month": "02", "Day": "26"}], "Journal": {"ISSN": "1559-1182", "JournalIssue": {"Volume": "48", "Issue": "1", "PubDate": {"Year": "2013", "Month": "Aug"}}, "Title": "Molecular neurobiology", "ISOAbbreviation": "Mol Neurobiol"}, "ArticleTitle": "Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.", "Pagination": {"StartPage": "190", "EndPage": "204", "MedlinePgn": "190-204"}, "Abstract": {"AbstractText": ["Activation of the Toll-like receptor 4 (TLR4) complex, a receptor of the innate immune system, may underpin the pathophysiology of many human diseases, including asthma, cardiovascular disorder, diabetes, obesity, metabolic syndrome, autoimmune disorders, neuroinflammatory disorders, schizophrenia, bipolar disorder, autism, clinical depression, chronic fatigue syndrome, alcohol abuse, and toluene inhalation. TLRs are pattern recognition receptors that recognize damage-associated molecular patterns and pathogen-associated molecular patterns, including lipopolysaccharide (LPS) from gram-negative bacteria. Here we focus on the environmental factors, which are known to trigger TLR4, e.g., ozone, atmosphere particulate matter, long-lived reactive oxygen intermediate, pentachlorophenol, ionizing radiation, and toluene. Activation of the TLR4 pathways may cause chronic inflammation and increased production of reactive oxygen and nitrogen species (ROS/RNS) and oxidative and nitrosative stress and therefore TLR-related diseases. This implies that drugs or substances that modify these pathways may prevent or improve the abovementioned diseases. Here we review some of the most promising drugs and agents that have the potential to attenuate TLR-mediated inflammation, e.g., anti-LPS strategies that aim to neutralize LPS (synthetic anti-LPS peptides and recombinant factor C) and TLR4/MyD88 antagonists, including eritoran, CyP, EM-163, epigallocatechin-3-gallate, 6-shogaol, cinnamon extract, N-acetylcysteine, melatonin, and molecular hydrogen. The authors posit that activation of the TLR radical (ROS/RNS) cycle is a common pathway underpinning many \"civilization\" disorders and that targeting the TLR radical cycle may be an effective method to treat many inflammatory disorders."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Sportzenkoppel 54, 22359, Hamburg, Germany."}], "Identifier": [], "LastName": "Lucas", "ForeName": "Kurt", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Maes", "ForeName": "Michael", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mol Neurobiol", "NlmUniqueID": "8900963", "ISSNLinking": "0893-7648"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Chronic Disease"}, {"QualifierName": [], "DescriptorName": "Environment"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Molecular Targeted Therapy"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Toll-Like Receptor 4"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Jeong E, Lee JY. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J. 2011;52(3):379\u201392. doi: 10.3349/ymj.2011.52.3.379.", "ArticleIdList": ["10.3349/ymj.2011.52.3.379", "PMC3101043", "21488180"]}, {"Citation": "Mu HH, Hasebe A, Van Schelt A, Cole BC. Novel interactions of a microbial superantigen with TLR2 and TLR4 differentially regulate IL-17 and Th17-associated cytokines. Cell Microbiol. 2011;13(3):374\u201387. doi: 10.1111/j.1462-5822.2010.01540.x.", "ArticleIdList": ["10.1111/j.1462-5822.2010.01540.x", "20946245"]}, {"Citation": "Oliveira-Nascimento L, Massari P, Wetzler LM. The role of TLR2 in infection and immunity. Front Immunol. 2012;3:79. doi: 10.3389/fimmu.2012.00079.", "ArticleIdList": ["10.3389/fimmu.2012.00079", "PMC3342043", "22566960"]}, {"Citation": "Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133(2):235\u201349. doi: 10.1016/j.cell.2008.02.043.", "ArticleIdList": ["10.1016/j.cell.2008.02.043", "PMC7112336", "18423196"]}, {"Citation": "Lefebvre JS, L\u00e9vesque T, Picard S, Par\u00e9 G, Gravel A, Flamand L, Borgeat P. Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4. Arthritis Rheum. 2011;63(6):1527\u201333. doi: 10.1002/art.30308.", "ArticleIdList": ["10.1002/art.30308", "21360520"]}, {"Citation": "Sirisinha S. Insight into the mechanisms regulating immune homeostasis in health and disease. Asian Pac J Allergy Immunol. 2011;29(1):1\u201314.", "ArticleIdList": ["21560483"]}, {"Citation": "Kerkhof M, Postma DS, Brunekreef B, Reijmerink NE, Wijga AH, de Jongste JC, Gehring U, Koppelman GH. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax. 2010;65(8):690\u20137. doi: 10.1136/thx.2009.119636.", "ArticleIdList": ["10.1136/thx.2009.119636", "20685742"]}, {"Citation": "Budulac SE, Boezen HM, Hiemstra PS, Lapperre TS, Vonk JM, Timens W, Postma DS, GLUCOLD study group Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease. PLoS One. 2012;7(8):e43124. doi: 10.1371/journal.pone.0043124.", "ArticleIdList": ["10.1371/journal.pone.0043124", "PMC3429472", "22952638"]}, {"Citation": "Kashiwagi M, Imanishi T, Ozaki Y, Satogami K, Masuno T, Wada T, Nakatani Y, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Akasaka T. Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction. Atherosclerosis. 2012;221(1):249\u201353. doi: 10.1016/j.atherosclerosis.2011.12.030.", "ArticleIdList": ["10.1016/j.atherosclerosis.2011.12.030", "22244044"]}, {"Citation": "Spirig R, Tsui J, Shaw S. The emerging role of TLR and innate immunity in cardiovascular disease. Cardiol Res Pract. 2012;2012:181394.", "ArticleIdList": ["PMC3346970", "22577589"]}, {"Citation": "Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010;11(2):155\u201361. doi: 10.1038/ni.1836.", "ArticleIdList": ["10.1038/ni.1836", "PMC2809046", "20037584"]}, {"Citation": "Downes CE, Crack PJ. Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol. 2010;160(8):1872\u201388. doi: 10.1111/j.1476-5381.2010.00864.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00864.x", "PMC2958633", "20649586"]}, {"Citation": "Pimentel-Nunes P, Teixeira AL, Pereira C, Gomes M, Brand\u00e3o C, Rodrigues C, Gon\u00e7alves N, Boal-Carvalho I, Roncon-Albuquerque R, Jr, Moreira-Dias L, Leite-Moreira AF, Medeiros R, Dinis-Ribeiro M. Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans. Dig Liver Dis. 2013;45(1):63\u201369. doi: 10.1016/j.dld.2012.08.006.", "ArticleIdList": ["10.1016/j.dld.2012.08.006", "22999059"]}, {"Citation": "Ladefoged M, Buschard K, Hansen AM (2013) Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes. APMIS doi:. doi:10.1111/apm.12018", "ArticleIdList": ["23134512"]}, {"Citation": "Amyot J, Semache M, Ferdaoussi M, Font\u00e9s G, Poitout V. Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-like receptor-4 and NF-\u03baB signalling. PLoS One. 2012;7(4):e36200. doi: 10.1371/journal.pone.0036200.", "ArticleIdList": ["10.1371/journal.pone.0036200", "PMC3338606", "22558381"]}, {"Citation": "Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356\u20139. doi: 10.1001/jama.287.3.356.", "ArticleIdList": ["10.1001/jama.287.3.356", "11790215"]}, {"Citation": "Jialal I, Huet BA, Kaur H, Chien A, Devaraj S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012;35(4):900\u20134. doi: 10.2337/dc11-2375.", "ArticleIdList": ["10.2337/dc11-2375", "PMC3308307", "22357188"]}, {"Citation": "McKernan DP, Dennison U, Gaszner G, Cryan JF, Dinan TG. Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl Psychiatry. 2011;1:e36. doi: 10.1038/tp.2011.37.", "ArticleIdList": ["10.1038/tp.2011.37", "PMC3309507", "22832610"]}, {"Citation": "Enstrom AM, Onore CE, Van de Water JA, Ashwood P Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain BehavImmun. 2010;24(1):64\u201371.", "ArticleIdList": ["PMC3014091", "19666104"]}, {"Citation": "Kanuri G, Weber S, Volynets V, Spruss A, Bischoff SC, Bergheim I. Cinnamon extract protects against acute alcohol-induced liver steatosis in mice. J Nutr. 2009;139(3):482\u20137. doi: 10.3945/jn.108.100495.", "ArticleIdList": ["10.3945/jn.108.100495", "19126670"]}, {"Citation": "Maes M, Kubera M, Leunis JC. The gut\u2013brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008;29(1):117\u201324.", "ArticleIdList": ["18283240"]}, {"Citation": "Maes M, Mihaylova I, Leunis JC. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J Affect Disord. 2007;99(1\u20133):237\u201340. doi: 10.1016/j.jad.2006.08.021.", "ArticleIdList": ["10.1016/j.jad.2006.08.021", "17007934"]}, {"Citation": "Maes M, Kubera M, Leunis JC, Berk M, Geffard M, Bosmans E (2013) In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand. doi:10.1111/j.1600-0447.2012.01908.x", "ArticleIdList": ["22900942"]}, {"Citation": "Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE. Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. Scand J Gastroenterol. 1993;28(7):573\u201380. doi: 10.3109/00365529309096090.", "ArticleIdList": ["10.3109/00365529309096090", "8362208"]}, {"Citation": "Sundqvist T, Lindstr\u00f6m F, Magnusson KE, Sk\u00f6ldstam L, Stjernstr\u00f6m I, Tagesson C. Influence of fasting on intestinal permeability and disease activity in patients with rheumatoid arthritis. Scand J Rheumatol. 1982;11(1):33\u20138. doi: 10.3109/03009748209098111.", "ArticleIdList": ["10.3109/03009748209098111", "7063809"]}, {"Citation": "Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ. Alzheimer\u2019s disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis. 2008;13(4):437\u201349.", "ArticleIdList": ["18487851"]}, {"Citation": "Gabrielli M, Bonazzi P, Scarpellini E, Bendia E, Lauritano EC, Fasano A, Ceravolo MG, Capecci M, Rita Bentivoglio A, Provinciali L, Tonali PA, Gasbarrini A. Prevalence of small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord. 2011;26(5):889\u201392. doi: 10.1002/mds.23566.", "ArticleIdList": ["10.1002/mds.23566", "21520278"]}, {"Citation": "Ochoa-Rep\u00e1raz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol. 2011;69(2):240\u20137. doi: 10.1002/ana.22344.", "ArticleIdList": ["10.1002/ana.22344", "21387369"]}, {"Citation": "Geffard M, Bodet D, Martinet Y, Dabadie M-P. Detection of the specific IgM and IgA circulating in sera of multiple sclerosis patients: interest and perspectives. Immuno-Analyse and Biol Spec. 2002;17:302\u2013310."}, {"Citation": "Shanahan F. Current concepts of the pathogenesis of inflammatory bowel disease. Ir J Med Sci. 1994;163(12):544\u20139. doi: 10.1007/BF02943022.", "ArticleIdList": ["10.1007/BF02943022", "7843934"]}, {"Citation": "Krack A, Sharma R, Figulla HR, Anker SD. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J. 2005;26(22):2368\u201374. doi: 10.1093/eurheartj/ehi389.", "ArticleIdList": ["10.1093/eurheartj/ehi389", "15980032"]}, {"Citation": "Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M, Poole-Wilson P, Volk HD, Lochs H, Anker SD. Altered intestinal function in patients with chronic heart failure. J Am CollCardiol. 2007;50(16):1561\u20139. doi: 10.1016/j.jacc.2007.07.016.", "ArticleIdList": ["10.1016/j.jacc.2007.07.016", "17936155"]}, {"Citation": "Sandek A, Rauchhaus M, Anker SD, von Haehling S. The emerging role of the gut in chronic heart failure. Curr Opin Clin Nutr Metab Care. 2008;11(5):632\u20139. doi: 10.1097/MCO.0b013e32830a4c6e.", "ArticleIdList": ["10.1097/MCO.0b013e32830a4c6e", "18685461"]}, {"Citation": "Charalambous BM, Stephens RC, Feavers IM, Montgomery HE. Role of bacterial endotoxin in chronic heart failure: the gut of the matter. Shock. 2007;28(1):15\u201323. doi: 10.1097/shk.0b013e318033ebc5.", "ArticleIdList": ["10.1097/shk.0b013e318033ebc5", "17510602"]}, {"Citation": "Arai H, Furuya T, Yasuda T, Miura M, Mizuno Y, Mochizuki H. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice. J BiolChem. 2004;279(49):51647\u201353.", "ArticleIdList": ["15383538"]}, {"Citation": "Gyurcsovics K, Bert\u00f3k L. Pathophysiology of psoriasis: coping endotoxins with bile acid therapy. Pathophysiology. 2003;10(1):57\u201361. doi: 10.1016/j.pathophys.2003.07.001.", "ArticleIdList": ["10.1016/j.pathophys.2003.07.001", "14643904"]}, {"Citation": "Hollingsworth JW, Kleeberger SR, Foster WM. Ozone and pulmonary innate immunity. Proc Am Thorac Soc. 2007;4(3):240\u20136. doi: 10.1513/pats.200701-023AW.", "ArticleIdList": ["10.1513/pats.200701-023AW", "PMC2647625", "17607006"]}, {"Citation": "Williams AS, Leung SY, Nath P, Khorasani NM, Bhavsar P, Issa R, Mitchell JA, Adcock IM, Chung KF. Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol. 2007;103(4):1189\u201395. doi: 10.1152/japplphysiol.00172.2007.", "ArticleIdList": ["10.1152/japplphysiol.00172.2007", "17626835"]}, {"Citation": "Oakes JL, O'Connor BP, Warg LA, Burton R, Hock A, Loader J, Laflamme D, Jing J, Hui L, Schwartz DA, Yang IV. Ozone enhances pulmonary innate immune response to a TLR2 agonist. Am J Respir Cell Mol Biol. 2013;48(1):27\u201334. doi: 10.1165/rcmb.2012-0187OC.", "ArticleIdList": ["10.1165/rcmb.2012-0187OC", "PMC3547086", "23002100"]}, {"Citation": "Connor AJ, Laskin JD, Laskin DL. Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4. Exp Mol Pathol. 2012;92(2):229\u201335. doi: 10.1016/j.yexmp.2012.01.004.", "ArticleIdList": ["10.1016/j.yexmp.2012.01.004", "PMC3507381", "22300504"]}, {"Citation": "Garantziotis S, Li Z, Potts EN, Lindsey JY, Stober VP, Polosukhin VV, Blackwell TS, Schwartz DA, Foster WM, Hollingsworth JW. TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am J RespirCrit Care Med. 2010;181(7):666\u201375. doi: 10.1164/rccm.200903-0381OC.", "ArticleIdList": ["10.1164/rccm.200903-0381OC", "PMC2868499", "20007931"]}, {"Citation": "Li Z, Potts-Kant EN, Garantziotis S, Foster WM, Hollingsworth JW. Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP. PLoS One. 2011;6(11):e27137. doi: 10.1371/journal.pone.0027137.", "ArticleIdList": ["10.1371/journal.pone.0027137", "PMC3208559", "22073274"]}, {"Citation": "Iuliano L. Pathways of cholesterol oxidation via non-enzymatic mechanisms. ChemPhys Lipids. 2011;164(6):457\u201368. doi: 10.1016/j.chemphyslip.2011.06.006.", "ArticleIdList": ["10.1016/j.chemphyslip.2011.06.006", "21703250"]}, {"Citation": "Lee C-W, Hsu D-J. Measurements of fine and ultrafine particles formation in photocopy centers in Taiwan. Atmospheric Environment. 2007;41(3):6598\u201309. doi: 10.1016/j.atmosenv.2007.04.016.", "ArticleIdList": ["10.1016/j.atmosenv.2007.04.016"]}, {"Citation": "Kampfrath T, Maiseyeu A, Ying Z, Shah Z, Deiuliis JA, Xu X, Kherada N, Brook RD, Reddy KM, Padture NP, Parthasarathy S, Chen LC, Moffatt-Bruce S, Sun Q, Morawietz H, Rajagopalan S. Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res. 2011;108(6):716\u201326. doi: 10.1161/CIRCRESAHA.110.237560.", "ArticleIdList": ["10.1161/CIRCRESAHA.110.237560", "PMC3085907", "21273555"]}, {"Citation": "US Environmental Protection Agency (2012) National Ambient Air Quality Standards (NAAQS), PM2.5 NAAQS Implementation http://www.epa.gov/ttn/naaqs/pm/pm25_index.html"}, {"Citation": "Miyata R, van Eeden SF. The innate and adaptive immune response induced by alveolar macrophages exposed to ambient particulate matter. Toxicol Appl Pharmacol. 2011;257(2):209\u201326. doi: 10.1016/j.taap.2011.09.007.", "ArticleIdList": ["10.1016/j.taap.2011.09.007", "21951342"]}, {"Citation": "Shiraiwa M, Sosedova Y, Rouvi\u00e8re A, Yang H, Zhang Y, Abbatt JP, Ammann M, P\u00f6schl U. The role of long-lived reactive oxygen intermediates in the reaction of ozone with aerosol particles. Nat Chem. 2011;3(4):291\u20135. doi: 10.1038/nchem.988.", "ArticleIdList": ["10.1038/nchem.988", "21430687"]}, {"Citation": "Gruijthuijsen YK, Grieshuber I, St\u00f6cklinger A, Tischler U, Fehrenbach T, Weller MG, Vogel L, Vieths S, P\u00f6schl U, Duschl A. Nitration enhances the allergenic potential of proteins. Int Arch Allergy Immunol. 2006;141(3):265\u201375. doi: 10.1159/000095296.", "ArticleIdList": ["10.1159/000095296", "16931888"]}, {"Citation": "Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci. 2004;77(2):347\u201357. doi: 10.1093/toxsci/kfh019.", "ArticleIdList": ["10.1093/toxsci/kfh019", "14600271"]}, {"Citation": "Chen P, Migita S, Kanehira K, Sonezaki S, Taniguchi A. Development of sensor cells using NF-\u03baB pathway activation for detection of nanoparticle-induced inflammation. Sensors (Basel) 2011;11(7):7219\u201330. doi: 10.3390/s110707219.", "ArticleIdList": ["10.3390/s110707219", "PMC3231678", "22164013"]}, {"Citation": "Cui Y, Liu H, Zhou M, Duan Y, Li N, Gong X, Hu R, Hong M, Hong F. Signaling pathway of inflammatory responses in the mouse liver caused by TiO2 nanoparticles. J Biomed Mater Res A. 2011;96(1):221\u20139.", "ArticleIdList": ["21105171"]}, {"Citation": "Dick CA, Brown DM, Donaldson K, Stone V. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal Toxicol. 2003;15(1):39\u201352. doi: 10.1080/08958370304454.", "ArticleIdList": ["10.1080/08958370304454", "12476359"]}, {"Citation": "Reeves JF, Davies SJ, Dodd NJ, Jha AN. Hydroxyl radicals (*OH) are associated with titanium dioxide (TiO(2)) nanoparticle-induced cytotoxicity and oxidative DNA damage in fish cells. Mutat Res. 2008;640(1\u20132):113\u201322.", "ArticleIdList": ["18258270"]}, {"Citation": "Ionita P, Conte M, Gilbert BC, Chechik V. Gold nanoparticle-initiated free radical oxidations and halogen abstractions. Org Biomol Chem. 2007;5(21):3504\u20139. doi: 10.1039/b711573c.", "ArticleIdList": ["10.1039/b711573c", "17943210"]}, {"Citation": "Xiong D, Fang T, Yu L, Sima X, Zhu W. Effects of nano-scale TiO2, ZnO and their bulk counterparts on zebrafish: acute toxicity, oxidative stress and oxidative damage. Sci Total Environ. 2011;409(8):1444\u201352. doi: 10.1016/j.scitotenv.2011.01.015.", "ArticleIdList": ["10.1016/j.scitotenv.2011.01.015", "21296382"]}, {"Citation": "Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol. 2006;40(14):4346\u201352. doi: 10.1021/es060589n.", "ArticleIdList": ["10.1021/es060589n", "16903269"]}, {"Citation": "Hu R, Gong X, Duan Y, Li N, Che Y, Cui Y, Zhou M, Liu C, Wang H, Hong F. Neurotoxicological effects and the impairment of spatial recognition memory in mice caused by exposure to TiO2 nanoparticles. Biomaterials. 2010;31(31):8043\u201350. doi: 10.1016/j.biomaterials.2010.07.011.", "ArticleIdList": ["10.1016/j.biomaterials.2010.07.011", "20692697"]}, {"Citation": "Wang J, Chen C, Liu Y, Jiao F, Li W, Lao F, Li Y, Li B, Ge C, Zhou G, Gao Y, Zhao Y, Chai Z. Potential neurological lesion after nasal instillation of TiO(2) nanoparticles in the anatase and rutile crystal phases. Toxicol Lett. 2008;183:72\u201380. doi: 10.1016/j.toxlet.2008.10.001.", "ArticleIdList": ["10.1016/j.toxlet.2008.10.001", "18992307"]}, {"Citation": "Yang EJ, Kim S, Kim JS, Choi IH. Inflammasome formation and IL-1\u03b2 release by human blood monocytes in response to silver nanoparticles. Biomaterials. 2012;33(28):6858\u201367. doi: 10.1016/j.biomaterials.2012.06.016.", "ArticleIdList": ["10.1016/j.biomaterials.2012.06.016", "22770526"]}, {"Citation": "Kim AS, Chae CH, Kim J, Choi JY, Kim SG, B\u0103ciut G. Silver nanoparticles induce apoptosis through the Toll-like receptor 2 pathway. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(6):789\u201398. doi: 10.1016/j.oooo.2012.01.019.", "ArticleIdList": ["10.1016/j.oooo.2012.01.019", "22668707"]}, {"Citation": "Jang S, Park JW, Cha HR, Jung SY, Lee JE, Jung SS, Kim JO, Kim SY, Lee CS, Park HS. Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation. Int J Nanomedicine. 2012;7:1329\u201343.", "ArticleIdList": ["PMC3310409", "22457593"]}, {"Citation": "Scarino A, No\u00ebl A, Renzi PM, Cloutier Y, Vincent R, Truchon G, Tardif R, Charbonneau M. Impact of emerging pollutants on pulmonary inflammation in asthmatic rats: ethanol vapors and agglomerated TiO2 nanoparticles. Inhal Toxicol. 2012;24(8):528\u201338. doi: 10.3109/08958378.2012.696741.", "ArticleIdList": ["10.3109/08958378.2012.696741", "22746402"]}, {"Citation": "Chen EY, Garnica M, Wang YC, Chen CS, Chin WC. Mucin secretion induced by titanium dioxide nanoparticles. PLoS One. 2011;6(1):e16198. doi: 10.1371/journal.pone.0016198.", "ArticleIdList": ["10.1371/journal.pone.0016198", "PMC3023769", "21283816"]}, {"Citation": "Schmidt M, Raghavan B, M\u00fcller V, Vogl T, Fejer G, Tchaptchet S, Keck S, Kalis C, Nielsen PJ, Galanos C, Roth J, Skerra A, Martin SF, Freudenberg MA, Goebeler M. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol. 2012;11(9):814\u20139. doi: 10.1038/ni.1919.", "ArticleIdList": ["10.1038/ni.1919", "20711192"]}, {"Citation": "Raghavan B, Martin SF, Esser PR, Goebeler M, Schmidt M. Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2. EMBO Rep. 2012;13(12):1109\u201315. doi: 10.1038/embor.2012.155.", "ArticleIdList": ["10.1038/embor.2012.155", "PMC3512400", "23059983"]}, {"Citation": "Takahashi H, Kinbara M, Sato N, Sasaki K, Sugawara S, Endo Y. Nickel allergy-promoting effects of microbial or inflammatory substances at the sensitization step in mice. Int Immunopharmacol. 2011;11(10):1534\u201340. doi: 10.1016/j.intimp.2011.05.010.", "ArticleIdList": ["10.1016/j.intimp.2011.05.010", "21621645"]}, {"Citation": "Lerner A. Aluminum as an adjuvant in Crohn\u2019s disease induction. Lupus. 2012;21(2):231\u20138. doi: 10.1177/0961203311430090.", "ArticleIdList": ["10.1177/0961203311430090", "22235058"]}, {"Citation": "Koedrith P, Seo YR. Advances in carcinogenic metal toxicity and potential molecular markers. Int J Mol Sci. 2011;12(12):9576\u201395. doi: 10.3390/ijms12129576.", "ArticleIdList": ["10.3390/ijms12129576", "PMC3257147", "22272150"]}, {"Citation": "Reiter RJ, Manchester LC, Tan DX. Neurotoxins: free radical mechanisms and melatonin protection. Curr Neuropharmacol. 2010;8(3):194\u2013210. doi: 10.2174/157015910792246236.", "ArticleIdList": ["10.2174/157015910792246236", "PMC3001213", "21358970"]}, {"Citation": "Li H, Nookala S, Re F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol. 2007;178(8):5271\u20136.", "ArticleIdList": ["17404311"]}, {"Citation": "Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H, Kielland A, Vosters O, Vanderheyde N, Schiavetti F, Larocque D, Van Mechelen M, Gar\u00e7on N. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol. 2009;183(10):6186\u201397. doi: 10.4049/jimmunol.0901474.", "ArticleIdList": ["10.4049/jimmunol.0901474", "19864596"]}, {"Citation": "Poovala VS, Huang H, Salahudeen AK. Role of reactive oxygen metabolites in organophosphate-bidrin-induced renal tubular cytotoxicity. J Am Soc Nephrol. 1999;10(8):1746\u201352.", "ArticleIdList": ["10446942"]}, {"Citation": "Alluwaimi AM, Hussein Y. Diazinon immunotoxicity in mice: modulation of cytokines level and their gene expression. Toxicology. 2007;236(1\u20132):123\u201331. doi: 10.1016/j.tox.2007.04.004.", "ArticleIdList": ["10.1016/j.tox.2007.04.004", "17499902"]}, {"Citation": "Singh AK, Jiang Y. Lipopolysaccharide (LPS) induced activation of the immune system in control rats and rats chronically exposed to a low level of the organothiophosphate insecticide, acephate. Toxicol Ind Health. 2003;19(2\u20136):93\u2013108. doi: 10.1191/0748233703th181oa.", "ArticleIdList": ["10.1191/0748233703th181oa", "15697179"]}, {"Citation": "Pestka J, Zhou HR. Toll-like receptor priming sensitizes macrophages to proinflammatory cytokine gene induction by deoxynivalenol and other toxicants. Toxicol Sci. 2006;92(2):445\u201355. doi: 10.1093/toxsci/kfl012.", "ArticleIdList": ["10.1093/toxsci/kfl012", "16687389"]}, {"Citation": "Bohonowych JE, Zhao B, Timme-Laragy A, Jung D, Di Giulio RT, Denison MS. Newspapers and newspaper ink contain agonists for the ah receptor. Toxicol Sci. 2008;102(2):278\u201390. doi: 10.1093/toxsci/kfn011.", "ArticleIdList": ["10.1093/toxsci/kfn011", "PMC2855230", "18203687"]}, {"Citation": "Masuda K, Kimura A, Hanieh H, Nguyen NT, Nakahama T, Chinen I, Otoyo Y, Murotani T, Yamatodani A, Kishimoto T. Aryl hydrocarbon receptor negatively regulates LPS-induced IL-6 production through suppression of histamine production in macrophages. Int Immunol. 2011;23(10):637\u201345. doi: 10.1093/intimm/dxr072.", "ArticleIdList": ["10.1093/intimm/dxr072", "21930594"]}, {"Citation": "Zhu BZ, Shan GQ. Potential mechanism for pentachlorophenol-induced carcinogenicity: a novel mechanism for metal-independent production of hydroxyl radicals. Chem Res Toxicol. 2009;22(6):969\u201377. doi: 10.1021/tx900030v.", "ArticleIdList": ["10.1021/tx900030v", "19408893"]}, {"Citation": "Ohnishi T, Yoshida T, Igarashi A, Muroi M, Tanamoto K. Effects of possible endocrine disruptors on MyD88-independent TLR4 signaling. FEMS Immunol Med Microbiol. 2008;52(2):293\u20135. doi: 10.1111/j.1574-695X.2007.00355.x.", "ArticleIdList": ["10.1111/j.1574-695X.2007.00355.x", "18177342"]}, {"Citation": "Sethi G, Sodhi A. In vitro activation of murine peritoneal macrophages by ultraviolet B radiation: upregulation of CD18, production of NO, proinflammatory cytokines and a signal transduction pathway. Mol Immunol. 2004;40(18):1315\u201323. doi: 10.1016/j.molimm.2004.01.001.", "ArticleIdList": ["10.1016/j.molimm.2004.01.001", "15072850"]}, {"Citation": "Yamamoto T, Kimura T, Ueta E, Tatemoto Y, Osaki T. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns. Oncology. 2003;64(4):407\u201315. doi: 10.1159/000070300.", "ArticleIdList": ["10.1159/000070300", "12759539"]}, {"Citation": "Shan YX, Jin SZ, Liu XD, Liu Y, Liu SZ. Ionizing radiation stimulates secretion of pro-inflammatory cytokines: dose\u2013response relationship, mechanisms and implications. Radiat Environ Biophys. 2007;46(1):21\u20139. doi: 10.1007/s00411-006-0076-x.", "ArticleIdList": ["10.1007/s00411-006-0076-x", "17072632"]}, {"Citation": "Hayashi T, Morishita Y, Khattree R, Misumi M, Sasaki K, Hayashi I, Yoshida K, Kajimura J, Kyoizumi S, Imai K, Kusunoki Y, Nakachi K. Evaluation of systemic markers of inflammation in atomic-bomb survivors with special reference to radiation and age effects. FASEB J. 2012;26(11):4765\u201373. doi: 10.1096/fj.12-215228.", "ArticleIdList": ["10.1096/fj.12-215228", "PMC3475247", "22872680"]}, {"Citation": "Heyman SN, Rosen S, Khamaisi M, Id\u00e9e JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45(4):188\u201395. doi: 10.1097/RLI.0b013e3181d2eed8.", "ArticleIdList": ["10.1097/RLI.0b013e3181d2eed8", "20195159"]}, {"Citation": "Marquette C, Linard C, Galonnier M, Van Uye A, Mathieu J, Gourmelon P, Claren\u00e7on D. IL-1beta, TNFalpha and IL-6 induction in the rat brain after partial-body irradiation: role of vagal afferents. Int J Radiat Biol. 2003;79(10):777\u201385. doi: 10.1080/09553000310001610998.", "ArticleIdList": ["10.1080/09553000310001610998", "14630536"]}, {"Citation": "Taylor AG, Goehler LE, Galper DI, Innes KE, Bourguignon C. Top-down and bottom-up mechanisms in mind-body medicine: development of an integrative framework for psychophysiological research. Explore (NY) 2010;6(1):29\u201341. doi: 10.1016/j.explore.2009.10.004.", "ArticleIdList": ["10.1016/j.explore.2009.10.004", "PMC2818254", "20129310"]}, {"Citation": "Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G (2009) Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev(1):CD006953. doi:10.1002/14651858.CD006953.pub2", "ArticleIdList": ["PMC7197415", "19160308"]}, {"Citation": "Morris G, Maes M (2012) A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome. Metab Brain Dis doi:10.1007/s11011-012-9324-8", "ArticleIdList": ["22718491"]}, {"Citation": "Shakhov AN, Singh VK, Bone F, Cheney A, Kononov Y, Krasnov P, Bratanova-Toshkova TK, Shakhova VV, Young J, Weil MM, Panoskaltsis-Mortari A, Orschell CM, Baker PS, Gudkov A, Feinstein E. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2) PLoS One. 2012;7(3):e33044. doi: 10.1371/journal.pone.0033044.", "ArticleIdList": ["10.1371/journal.pone.0033044", "PMC3314012", "22479357"]}, {"Citation": "Riehl TE, Foster L, Stenson WF. Hyaluronic acid is radioprotective in the intestine through a TLR4 and COX-2-mediated mechanism. Am J Physiol Gastrointest Liver Physiol. 2011;302(3):G309\u201316. doi: 10.1152/ajpgi.00248.2011.", "ArticleIdList": ["10.1152/ajpgi.00248.2011", "PMC3287404", "22038822"]}, {"Citation": "Borne J, Riascos R, Cuellar H, Vargas D, Rojas R. Neuroimaging in drug and substance abuse part II: opioids and solvents. Top Magn Reson Imaging. 2005;16(3):239\u201345. doi: 10.1097/01.rmr.0000192154.34563.6b.", "ArticleIdList": ["10.1097/01.rmr.0000192154.34563.6b", "16340648"]}, {"Citation": "Win-Shwe TT, Kunugita N, Yoshida Y, Fujimaki H. Role of hippocampal TLR4 in neurotoxicity in mice following toluene exposure. Neurotoxicol Teratol. 2011;33(5):598\u2013602. doi: 10.1016/j.ntt.2011.07.005.", "ArticleIdList": ["10.1016/j.ntt.2011.07.005", "21802510"]}, {"Citation": "Mart\u00ednez-Alfaro M, C\u00e1rabez-Trejo A, Gallegos-Corona MA, Pedraza-Aboytes G, Hern\u00e1ndez-Chan NG, Leo-Amador GE. Thinner inhalation effects on oxidative stress and DNA repair in a rat model of abuse. J Appl Toxicol. 2010;30(3):226\u201332.", "ArticleIdList": ["19885856"]}, {"Citation": "Bailey MT, Engler H, Powell ND, Padgett DA, Sheridan JF. Repeated social defeat increases the bactericidal activity of splenic macrophages through a Toll-like receptor-dependent pathway. Am J Physiol Regul Integr Comp Physiol. 2007;293(3):R1180\u201390. doi: 10.1152/ajpregu.00307.2007.", "ArticleIdList": ["10.1152/ajpregu.00307.2007", "17596326"]}, {"Citation": "Garc\u00eda-Bueno B, Madrigal JL, P\u00e9rez-Nievas BG, Leza JC. Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. Endocrinology. 2008;149(4):1969\u201378. doi: 10.1210/en.2007-0482.", "ArticleIdList": ["10.1210/en.2007-0482", "18079203"]}, {"Citation": "Caso JR, Pradillo JM, Hurtado O, Leza JC, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke. 2008;39(4):1314\u201320. doi: 10.1161/STROKEAHA.107.498212.", "ArticleIdList": ["10.1161/STROKEAHA.107.498212", "18309167"]}, {"Citation": "Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol. 2007;9(9):1081\u20138. doi: 10.1038/ncb1629.", "ArticleIdList": ["10.1038/ncb1629", "17704767"]}, {"Citation": "Tancowny BP, Karpov V, Schleimer RP, Kulka M. Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2. Immunology. 2010;131(2):220\u201330. doi: 10.1111/j.1365-2567.2010.03296.x.", "ArticleIdList": ["10.1111/j.1365-2567.2010.03296.x", "PMC2967268", "20497485"]}, {"Citation": "Hultqvist M, Olofsson P, Holmberg J, B\u00e4ckstr\u00f6m BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A. 2004;101(34):12646\u201351. doi: 10.1073/pnas.0403831101.", "ArticleIdList": ["10.1073/pnas.0403831101", "PMC515111", "15310853"]}, {"Citation": "Kadl A, Sharma PR, Chen W, Agrawal R, Meher AK, Rudraiah S, Grubbs N, Sharma R, Leitinger N. Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2. Free Radic Biol Med. 2011;51(10):1903\u20139. doi: 10.1016/j.freeradbiomed.2011.08.026.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.08.026", "PMC3197756", "21925592"]}, {"Citation": "Kaconis Y, Kowalski I, Howe J, Brauser A, Richter W, Razquin-Olazar\u00e1n I, I\u00f1igo-Pesta\u00f1a M, Garidel P, R\u00f6ssle M, Martinez de Tejada G, Gutsmann T, Brandenburg K. Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides. Biophys J. 2011;100(11):2652\u201361. doi: 10.1016/j.bpj.2011.04.041.", "ArticleIdList": ["10.1016/j.bpj.2011.04.041", "PMC3117184", "21641310"]}, {"Citation": "Li P, Ho B, Ding JL. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity. J Endotoxin Res. 2007;13(3):150\u20137. doi: 10.1177/0968051907079573.", "ArticleIdList": ["10.1177/0968051907079573", "17621557"]}, {"Citation": "Lu Z, Zhang X, Li Y, Jin J, Huang Y. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. J Endocrinol. 2013;216(1):61\u201371. doi: 10.1530/JOE-12-0338.", "ArticleIdList": ["10.1530/JOE-12-0338", "23060524"]}, {"Citation": "Christianson CA, Dumlao DS, Stokes JA, Dennis EA, Svensson CI, Corr M, Yaksh TL. Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis. Pain. 2011;152(12):2881\u201391. doi: 10.1016/j.pain.2011.09.020.", "ArticleIdList": ["10.1016/j.pain.2011.09.020", "PMC3347973", "22019135"]}, {"Citation": "Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM; Eritoran Sepsis Study Group Phase 2 trial of eritorantetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit Care Med. 2010;38(1):72\u201383. doi: 10.1097/CCM.0b013e3181b07b78.", "ArticleIdList": ["10.1097/CCM.0b013e3181b07b78", "19661804"]}, {"Citation": "Macagno A, Molteni M, Rinaldi A, Bertoni F, Lanzavecchia A, Rossetti C, Sallusto F. A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J Exp Med. 2006;203(6):1481\u201392. doi: 10.1084/jem.20060136.", "ArticleIdList": ["10.1084/jem.20060136", "PMC2118317", "16717116"]}, {"Citation": "Peri F, Piazza M. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Biotechnol Adv. 2012;30(1):251\u201360. doi: 10.1016/j.biotechadv.2011.05.014.", "ArticleIdList": ["10.1016/j.biotechadv.2011.05.014", "21664961"]}, {"Citation": "Youn HS, Lee JY, Saitoh SI, Miyake K, Kang KW, Choi YJ, Hwang DH. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (\u2212)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem Pharmacol. 2006;72(7):850\u20139. doi: 10.1016/j.bcp.2006.06.021.", "ArticleIdList": ["10.1016/j.bcp.2006.06.021", "16890209"]}, {"Citation": "Kuang X, Huang Y, Gu HF, Zu XY, Zou WY, Song ZB, Guo QL. Effects of intrathecalepigallocatechingallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats. Eur J Pharmacol. 2012;676(1\u20133):51\u20136. doi: 10.1016/j.ejphar.2011.11.037.", "ArticleIdList": ["10.1016/j.ejphar.2011.11.037", "22173123"]}, {"Citation": "Park SJ, Lee MY, Son BS, Youn HS. TBK1-targeted suppression of TRIF-dependent signaling pathway of Toll-like receptors by 6-shogaol, an active component of ginger. Biosci Biotechnol Biochem. 2009;73(7):1474\u20138. doi: 10.1271/bbb.80738.", "ArticleIdList": ["10.1271/bbb.80738", "19584560"]}, {"Citation": "Liu CL, Xie LX, Li M, Durairajan SS, Goto S, Huang JD. Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling. PLoS One. 2007;2(12):e1321. doi: 10.1371/journal.pone.0001321.", "ArticleIdList": ["10.1371/journal.pone.0001321", "PMC2117346", "18091994"]}, {"Citation": "Wang X, Wang Y, Jiang M, Zhu Y, Hu L, Fan G, Wang Y, Li X, Gao X. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways. J Ethnopharmacol. 2011;135(3):662\u201371. doi: 10.1016/j.jep.2011.03.070.", "ArticleIdList": ["10.1016/j.jep.2011.03.070", "21497648"]}, {"Citation": "Youn HS, Saitoh SI, Miyake K, Hwang DH. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol. 2006;72(1):62\u20139. doi: 10.1016/j.bcp.2006.03.022.", "ArticleIdList": ["10.1016/j.bcp.2006.03.022", "16678799"]}, {"Citation": "Kissner TL, Ruthel G, Alam S, Mann E, Ajami D, Rebek M, Larkin E, Fernandez S, Ulrich RG, Ping S, Waugh DS, Rebek J, Jr, Saikh KU. Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88. PLoS One. 2012;7(7):e40773. doi: 10.1371/journal.pone.0040773.", "ArticleIdList": ["10.1371/journal.pone.0040773", "PMC3407147", "22848400"]}, {"Citation": "Hsing CH, Lin MC, Choi PC, Huang WC, Kai JI, Tsai CC, Cheng YL, Hsieh CY, Wang CY, Chang YP, Chen YH, Chen CL, Lin CF. Anesthetic propofol reduces endotoxic inflammation by inhibiting reactive oxygen species-regulated Akt/IKK\u03b2/NF-\u03baB signaling. PLoS One. 2011;6(3):e17598. doi: 10.1371/journal.pone.0017598.", "ArticleIdList": ["10.1371/journal.pone.0017598", "PMC3050912", "21408125"]}, {"Citation": "Chiu WT, Lin YL, Chou CW, Chen RM. Propofol inhibits lipoteichoic acid-induced iNOS gene expression in macrophages possibly through downregulation of toll-like receptor 2-mediated activation of Raf-MEK1/2-ERK1/2-IKK-NFkappaB. Chem Biol Interact. 2009;181(3):430\u20139. doi: 10.1016/j.cbi.2009.06.011.", "ArticleIdList": ["10.1016/j.cbi.2009.06.011", "19573522"]}, {"Citation": "Wu Y, Li W, Zhou C, Lu F, Gao T, Liu Y, Cao J, Zhang Y, Zhang Y, Zhou C. Ketamine inhibits lipopolysaccharide-induced astrocytes activation by suppressing TLR4/NF-\u0138B pathway. Cell Physiol Biochem. 2012;30(3):609\u201317. doi: 10.1159/000341442.", "ArticleIdList": ["10.1159/000341442", "22832327"]}, {"Citation": "Montezano AC, Touyz RM. Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: a basic science update for the clinician. Can J Cardiol. 2012;28(3):288\u201395. doi: 10.1016/j.cjca.2012.01.017.", "ArticleIdList": ["10.1016/j.cjca.2012.01.017", "22445098"]}, {"Citation": "Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI. N-acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008;64(6):468\u201375. doi: 10.1016/j.biopsych.2008.04.022.", "ArticleIdList": ["10.1016/j.biopsych.2008.04.022", "18534556"]}, {"Citation": "Magalh\u00e3es PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M. N-acetylcysteine for major depressive episodes in bipolar disorder. Rev Bras Psiquiatr. 2011;33(4):374\u20138. doi: 10.1590/S1516-44462011000400011.", "ArticleIdList": ["10.1590/S1516-44462011000400011", "22189927"]}, {"Citation": "Smaga I, Pomierny B, Krzy\u00f3anowska W, Pomierny-Chamio\u0142o L, Miszkiel J, Niedzielska E, Og\u00f3rka A, Filip M. N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(2):280\u20137. doi: 10.1016/j.pnpbp.2012.06.018.", "ArticleIdList": ["10.1016/j.pnpbp.2012.06.018", "22820675"]}, {"Citation": "Hou Y, Wang L, Yi D, Ding B, Yang Z, Li J, Chen X, Qiu Y, Wu G (2013) N-acetylcysteine reduces inflammation in the small intestine by regulating redox, EGF and TLR4 signaling. Amino Acids (in press)", "ArticleIdList": ["22532030"]}, {"Citation": "Jung TS, Kim SK, Shin HJ, Jeon BT, Hahm JR, Roh GS. \u03b1-Lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats. Liver Int. 2012;32(10):1565\u201373. doi: 10.1111/j.1478-3231.2012.02857.x.", "ArticleIdList": ["10.1111/j.1478-3231.2012.02857.x", "22863080"]}, {"Citation": "Deiuliis JA, Kampfrath T, Ying Z, Maiseyeu A, Rajagopalan S. Lipoic acid attenuates innate immune infiltration and activation in the visceral adipose tissue of obese insulin resistant mice. Lipids. 2011;46(11):1021\u20131032. doi: 10.1007/s11745-011-3603-8.", "ArticleIdList": ["10.1007/s11745-011-3603-8", "PMC4849868", "21861137"]}, {"Citation": "Tian YF, Hsieh CH, Hsieh YJ, Chen YT, Peng YJ, Hsieh PS. \u03b1-Lipoic acid prevents mild portal endotoxaemia-induced hepatic inflammation and \u03b2 cell dysfunction. Eur J Clin Invest. 2012;42(6):637\u201348. doi: 10.1111/j.1365-2362.2011.02630.x.", "ArticleIdList": ["10.1111/j.1365-2362.2011.02630.x", "22121883"]}, {"Citation": "Honda H, Nagai Y, Matsunaga T, Saitoh S, Akashi-Takamura S, Hayashi H, Fujii I, Miyake K, Muraguchi A, Takatsu K. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner. J Leukoc Biol. 2012;91(6):967\u201376. doi: 10.1189/jlb.0112038.", "ArticleIdList": ["10.1189/jlb.0112038", "22422925"]}, {"Citation": "Ghanim H, Sia CL, Korzeniewski K, Lohano T, Abuaysheh S, Marumganti A, Chaudhuri A, Dandona P. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab. 2011;96(5):1409\u201314. doi: 10.1210/jc.2010-1812.", "ArticleIdList": ["10.1210/jc.2010-1812", "PMC3085195", "21289251"]}, {"Citation": "Kim SJ, Lee SM. Effect of baicalin on toll-like receptor 4-mediated ischemia/reperfusion inflammatory responses in alcoholic fatty liver condition. Toxicol Appl Pharmacol. 2012;258(1):43\u201350. doi: 10.1016/j.taap.2011.10.005.", "ArticleIdList": ["10.1016/j.taap.2011.10.005", "22019745"]}, {"Citation": "Hao H, Gufu H, Lei F, Dang L, Zhongliang Y. Baicalin suppresses expression of TLR2/4 and NF-\u03baB in Chlamydia trachomatis-infected mice. Immunopharmacol Immunotoxicol. 2012;34(1):89\u201394. doi: 10.3109/08923973.2011.580756.", "ArticleIdList": ["10.3109/08923973.2011.580756", "21612566"]}, {"Citation": "Tu XK, Yang WZ, Shi SS, Chen Y, Wang CH, Chen CM, Chen Z. Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation. 2011;34(5):463\u201370. doi: 10.1007/s10753-010-9254-8.", "ArticleIdList": ["10.1007/s10753-010-9254-8", "20859668"]}, {"Citation": "Ohno K, Ito M, Ichihara M, Ito M. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev. 2012;2012:353152. doi: 10.1155/2012/353152.", "ArticleIdList": ["10.1155/2012/353152", "PMC3377272", "22720117"]}, {"Citation": "Ito M, Ibi T, Sahashi K, Ichihara M, Ito M, Ohno K. Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies. Med Gas Res. 2011;1(1):24. doi: 10.1186/2045-9912-1-24.", "ArticleIdList": ["10.1186/2045-9912-1-24", "PMC3231939", "22146674"]}, {"Citation": "Li J, Dong Y, Chen H, Han H, Yu Y, Wang G, Zeng Y, Xie K. Protective effects of hydrogen-rich saline in a rat model of permanent focal cerebral ischemia via reducing oxidative stress and inflammatory cytokines. Brain Res. 2012;1486:103\u201311. doi: 10.1016/j.brainres.2012.09.031.", "ArticleIdList": ["10.1016/j.brainres.2012.09.031", "23010312"]}, {"Citation": "Xie K, Yu Y, Huang Y, Zheng L, Li J, Chen H, Han H, Hou L, Gong G, Wang G. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis. Shock. 2012;37(5):548\u201355.", "ArticleIdList": ["22508291"]}, {"Citation": "Taylor KE, Giddings JC, van den Berg CW. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2005;25(6):1225\u201330. doi: 10.1161/01.ATV.0000164623.41250.28.", "ArticleIdList": ["10.1161/01.ATV.0000164623.41250.28", "15802626"]}, {"Citation": "Kikkert R (2009) Toll-like receptors: tools, assays, and implications for in-vitro pyrogen tests. Thesis, University of Amsterdam, 29 September 2009"}, {"Citation": "J\u00f3zefowski S, Czerkies M, Sobota A, Kwiatkowska K. Determination of cell surface expression of Toll-like receptor 4 by cellular enzyme-linked immunosorbent assay and radiolabeling. Anal Biochem. 2011;413(2):185\u201391. doi: 10.1016/j.ab.2011.02.031.", "ArticleIdList": ["10.1016/j.ab.2011.02.031", "21354097"]}]}], "History": [{"Year": "2012", "Month": "12", "Day": "25"}, {"Year": "2013", "Month": "2", "Day": "5"}, {"Year": "2013", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "2", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["23436141", "PMC7091222", "10.1007/s12035-013-8425-7"]}}], "PubmedBookArticle": []}